Literature DB >> 22975496

Phagocytic entry of Legionella pneumophila into macrophages through phosphatidylinositol 3,4,5-trisphosphate-independent pathway.

Toshihiko Harada1, Takashi Tanikawa, Yasunori Iwasaki, Masao Yamada, Yasuyuki Imai, Masaki Miyake.   

Abstract

Legionella pneumophila, a causative agent of Legionnaire's disease, is an intracellular pathogen. It intervenes in the signal transduction of macrophages by secreting effector molecules through the Icm/Dot type IV secretion system (T4SS). There is a connection between signaling cascades that regulate phagocytosis and the production of reactive oxygen species (ROS). Class I phosphatidylinositol 3-kinase (PI3-K) and its product phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) play key roles in the reorganization of cytoskeleton (phagocytosis) and activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (ROS production). We investigated the production of PI(3,4,5)P3 and recruitment of class I PI3-K and Rac1 during phagocytosis of L. pneumophila by macrophages. Transient recruitment of class I PI3-K as well as PI(3,4,5)P3 production was observed around a phagocytosed T4SS mutant LELA3118 or avirulent mutant 25D in an early stage of infection. In contrast, class I PI3-K was recruited while accumulation of PI(3,4,5)P3 was not observed around wild type JR32. Immunoglobulin G (IgG)-opsonized live JR32, which would activate class I PI3-K through the Fcγ receptor pathway, did not induce PI(3,4,5)P3 production. Regardless of whether wild type or mutants were used, transient Rac1 accumulation was observed around bacteria. These results indicate that the phagocytosis of wild type L. pneumophila occurs via a special mechanism in which PI(3,4,5)P3 production is absent. This suggests that L. pneumophila may inhibit the production of PI(3,4,5)P3, but not the recruitment of class I PI3-K and Rac1, in a T4SS-dependent manner. L. pneumophila may start the modulation of host signaling cascade immediately after contact with host cells to evade the ROS-dependent bactericidal system while completing entry into macrophages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975496     DOI: 10.1248/bpb.b11-00011

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  A macrophage-stimulating compound from a screen of microbial natural products.

Authors:  Julie A Perry; Kalinka Koteva; Chris P Verschoor; Wenliang Wang; Dawn M E Bowdish; Gerry D Wright
Journal:  J Antibiot (Tokyo)       Date:  2014-07-02       Impact factor: 2.649

2.  Live-cell imaging of phosphoinositide dynamics and membrane architecture during Legionella infection.

Authors:  Stephen Weber; Maria Wagner; Hubert Hilbi
Journal:  MBio       Date:  2014-01-28       Impact factor: 7.867

3.  Amoebal endosymbiont Neochlamydia genome sequence illuminates the bacterial role in the defense of the host amoebae against Legionella pneumophila.

Authors:  Kasumi Ishida; Tsuyoshi Sekizuka; Kyoko Hayashida; Junji Matsuo; Fumihiko Takeuchi; Makoto Kuroda; Shinji Nakamura; Tomohiro Yamazaki; Mitsutaka Yoshida; Kaori Takahashi; Hiroki Nagai; Chihiro Sugimoto; Hiroyuki Yamaguchi
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

4.  Knockdown of the Rhipicephalus microplus cytochrome c oxidase subunit III gene is associated with a failure of Anaplasma marginale transmission.

Authors:  Thais D Bifano; Massaro W Ueti; Eliane Esteves; Kathryn E Reif; Glória R C Braz; Glen A Scoles; Reginaldo G Bastos; Stephen N White; Sirlei Daffre
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

Review 5.  The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases.

Authors:  Hor-Yue Tan; Ning Wang; Sha Li; Ming Hong; Xuanbin Wang; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2016-04-06       Impact factor: 6.543

Review 6.  Phosphoinositides and the Fate of Legionella in Phagocytes.

Authors:  A Leoni Swart; Hubert Hilbi
Journal:  Front Immunol       Date:  2020-01-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.